A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)
Condition: Primary Hypercholesterolemia Interventions: Drug: Ezetimibe; Drug: Placebo; Drug: Simivastatin; Drug: Statin Sponsor: Merck Sharp & Dohme Corp. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Cholesterol | Coronary Heart Disease | Heart | Heart Disease | Research | Statin Therapy | Study | Vytorin | Zetia